Ofer Nussbaum

1.8k total citations
38 papers, 1.3k citations indexed

About

Ofer Nussbaum is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Ofer Nussbaum has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Ofer Nussbaum's work include Hepatitis B Virus Studies (9 papers), Virus-based gene therapy research (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ofer Nussbaum is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Virus-based gene therapy research (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ofer Nussbaum collaborates with scholars based in Israel, United States and Germany. Ofer Nussbaum's co-authors include Edward A. Berger, Christopher C. Broder, Eithan Galun, Abraham Loyter, Mali Ketzinel‐Gilad, Ludmila Rivkin, Hilla Giladi, W. French Anderson, Shlomo Dagan and Ehud Ilan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Hepatology.

In The Last Decade

Ofer Nussbaum

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Nussbaum Israel 17 610 479 333 305 293 38 1.3k
Jason P. Gardner United States 22 537 0.9× 600 1.3× 734 2.2× 227 0.7× 228 0.8× 33 2.1k
Krystyna Bieńkowska-Szewczyk Poland 22 695 1.1× 500 1.0× 292 0.9× 118 0.4× 200 0.7× 61 1.5k
Yorihiro Nishimura Japan 24 566 0.9× 645 1.3× 316 0.9× 191 0.6× 183 0.6× 63 2.0k
Valerie Bosch Germany 20 452 0.7× 611 1.3× 416 1.2× 883 2.9× 288 1.0× 44 1.7k
Stefano Colloca Italy 26 785 1.3× 593 1.2× 514 1.5× 300 1.0× 565 1.9× 54 2.0k
Frances J. Palmer‐Hill United States 8 878 1.4× 325 0.7× 366 1.1× 97 0.3× 240 0.8× 8 1.3k
Karen V. Kibler United States 22 558 0.9× 671 1.4× 772 2.3× 567 1.9× 212 0.7× 44 1.9k
Donna M. Tscherne United States 12 1.3k 2.1× 476 1.0× 331 1.0× 150 0.5× 174 0.6× 15 2.1k
Heather J. Ezelle United States 16 327 0.5× 353 0.7× 389 1.2× 119 0.4× 138 0.5× 21 1.0k
Tam Nguyen United States 12 344 0.6× 837 1.7× 278 0.8× 93 0.3× 382 1.3× 15 1.4k

Countries citing papers authored by Ofer Nussbaum

Since Specialization
Citations

This map shows the geographic impact of Ofer Nussbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Nussbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Nussbaum more than expected).

Fields of papers citing papers by Ofer Nussbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Nussbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Nussbaum. The network helps show where Ofer Nussbaum may publish in the future.

Co-authorship network of co-authors of Ofer Nussbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Nussbaum. A scholar is included among the top collaborators of Ofer Nussbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Nussbaum. Ofer Nussbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nussbaum, Ofer, et al.. (2017). A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assays. Journal of Immunological Methods. 448. 85–90. 3 indexed citations
2.
Zeira, Evelyne, Eli Kedar, Michal Gropp, et al.. (2007). Femtosecond laser: a new intradermal DNA delivery method for efficient, long‐term gene expression and genetic immunization. The FASEB Journal. 21(13). 3522–3533. 28 indexed citations
3.
Ketzinel‐Gilad, Mali, Arie Zauberman, Ofer Nussbaum, et al.. (2006). The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. Hepatology Research. 34(4). 228–237. 15 indexed citations
4.
Galun, Eithan, Norah A. Terrault, Rachel Eren, et al.. (2006). Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity. Journal of Hepatology. 46(1). 37–44. 30 indexed citations
5.
Sikuler, Emanuel, David Tovbin, Lewis F. Neville, et al.. (2004). Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti‐E2‐antibody response. Journal of Medical Virology. 73(4). 529–535. 3 indexed citations
6.
Giladi, Hilla, et al.. (2003). Small interfering RNA Inhibits Hepatitis B virus replication in mice. Molecular Therapy. 8(5). 769–776. 248 indexed citations
8.
Ilan, Ehud, Ofer Nussbaum, Arie Zauberman, et al.. (2002). The Hepatitis C Virus (HCV)–Trimera Mouse: A Model for Evaluation of Agents against HCV. The Journal of Infectious Diseases. 185(2). 153–161. 69 indexed citations
9.
Ilan, Ehud, Rachel Eren, Ido Lubin, et al.. (2002). The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.. PubMed. 4(2). 102–9. 9 indexed citations
10.
Nussbaum, Ofer, Ehud Ilan, Ayelet Zauberman, et al.. (2001). Evaluation of human monoclonal antibodies to HCV in the HCV-trimera model: a mouse model for HCV infection. Journal of Hepatology. 34. 26–26. 2 indexed citations
11.
Galun, Eithan, Ahmed Eid, Oded Jurim, et al.. (2000). Human Interleukin-6 Facilitates Hepatitis B Virus Infection in Vitro and in Vivo. Virology. 270(2). 299–309. 29 indexed citations
12.
Eren, Rachel, Ehud Ilan, Ofer Nussbaum, et al.. (2000). Preclinical Evaluation of Two Human Anti-Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees. Hepatology. 32(3). 588–596. 66 indexed citations
13.
Ilan, Ehud, Shlomo Dagan, Ofer Nussbaum, et al.. (1999). The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic Agents. Hepatology. 29(2). 553–562. 81 indexed citations
15.
Nussbaum, Ofer, et al.. (1993). Fusion of Enveloped Viruses with Sperm Cells: Interaction of Sendai, Influenza, and Semliki Forest Viruses with Bull Spermatozoa. Experimental Cell Research. 206(1). 11–15. 15 indexed citations
17.
Nussbaum, Ofer, et al.. (1992). An inducer of NKCF (NK cytotoxic factor) release: Localization on target-cell membrane and initial characterization. Cellular Immunology. 142(2). 370–384. 6 indexed citations
18.
Reiter, Yoram, et al.. (1991). Resistance to NK Cell-Mediated Cytotoxicity (in K-562 Cells) does not Correlate with Class I MHC Antigen Levels. Immunobiology. 183(1-2). 23–39. 12 indexed citations
19.
Ran, Sophia, Ofer Nussbaum, Abraham Loyter, Y. Marikovsky, & Benjamin Rivnay. (1988). Reconstitution of fusogenic Sendai virus envelopes by the use of the detergent chaps. Archives of Biochemistry and Biophysics. 261(2). 437–446. 2 indexed citations
20.
Citovsky, Vitaly, et al.. (1988). Animal Viruses Are Able to Fuse with Prokaryotic Cells. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026